Dimensional Fund Advisors LP Talaris Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

  • $376 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$2.68 - $3.22 $493,926 - $593,449
184,301 Added 208.32%
272,773 $766,000
Q2 2023

Aug 09, 2023
BUY
$1.78 - $3.2 $157,480 - $283,110
88,472 New
88,472 $268,000
Q3 2022

Nov 10, 2022
SELL
$2.3 - $5.03 $919 - $2,012
-400 Reduced 2.19%
17,877 $47,000
Q2 2022

Aug 12, 2022
BUY
$4.51 - $9.85 $82,429 - $180,028
18,277 New
18,277 $82,000

Others Institutions Holding TALS

# of Institutions
2
Shares Held
75.7K
Call Options Held
0
Put Options Held
0
View Full List

About Talaris Therapeutics, Inc.

TALS Quotes by TradingView
  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email